Who is sponsoring NCT03696056?

NCT03696056 is sponsored by University of Texas at Austin.

What drugs are being tested in NCT03696056?

Interventions in NCT03696056: Kirtan Kriya meditation, Music listening program.

What condition does NCT03696056 study?

NCT03696056 studies Breast Cancer Survivors.

Is NCT03696056 still recruiting?

NCT03696056 is currently completed. Last updated 9 November 2020.

Last reviewed 2020-11-09 · How we verify

NCT03696056

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Improving Brain Function After Breast Cancer Study

Completed NA Last updated 9 November 2020

What this trial tests

NA trial testing Kirtan Kriya meditation in Breast Cancer Survivors in 36 participants. Completed in 30 January 2020.

Timeline

28 September 2018

Primary endpoint
1 January 2020

30 January 2020

Quick facts

Lead sponsor	University of Texas at Austin
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	36
Start date	28 September 2018
Primary completion	1 January 2020
Estimated completion	30 January 2020
Sites	1 location across United States

Drugs / interventions tested

Kirtan Kriya meditation
Music listening program

Conditions studied

Breast Cancer Survivors — all drugs for Breast Cancer Survivors →

Sponsor

University of Texas at Austin

Who can join

Adults 21 to 75, any sex, with Breast Cancer Survivors. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will explore the feasibility and potential effects of a simple, home-based daily meditation intervention on breast cancer survivors' cognitive and psychological functioning as well as inflammatory regulation.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

A randomized control trial of meditation compared to music listening to improve cognitive function for breast cancer survivors: Feasibility and acceptability.
Henneghan AM, Becker H, Harrison ML, Inselmann K, et al · · 2020 · cited 23× · PMID 32949954 · DOI 10.1016/j.ctcp.2020.101228
Effects of meditation compared to music listening on biomarkers in breast cancer survivors with cognitive complaints: secondary outcomes of a pilot randomized control trial.
Henneghan AM, Fico BG, Wright ML, Kesler SR, et al · · 2022 · cited 7× · PMID 34802955 · DOI 10.1016/j.explore.2021.10.011
Sustained effects of mantra meditation compared to music listening on neurocognitive outcomes of breast cancer survivors: A brief report of a randomized control trial.
Henneghan AM, Becker H, Phillips C, Kesler S. · · 2021 · cited 7× · PMID 34600308 · DOI 10.1016/j.jpsychores.2021.110628

Verify or expand the search:

Other recruiting trials for Breast Cancer Survivors

Currently open trials in the same condition.

NCT07379918 — Real-life Evaluation of Endopredict® in Early HR+/HER2- Breast Cancer · recruiting
NCT07334626 — Impact of Pilates Exercises on Bone Mineral Density in Breast Cancer Survivors Receiving Hormonal Therapy · NA · recruiting
NCT07280143 — The Development of MASLD Among Survivors of Breast or Colorectal Cancer · recruiting
NCT07214883 — UCF MammoChat: Image Repository · recruiting
NCT07284030 — Psychoeducation and Well-Being After Breast Cancer · NA · recruiting

Other University of Texas at Austin trials

Trials by the same sponsor.

NCT07319234 — Development of MENU Protocol · NA · not yet recruiting
NCT07480109 — Increased Dietary Protein Intake During GLP-1 Medication Use (in Middle-aged Women With Overweight/Obesity) · NA · not yet recruiting
NCT07069413 — Sibwatch: Optimizing Intervention Options for Infants and Toddler Siblings of Autistic Children · NA · not yet recruiting
NCT07370311 — A Culturally Adapted Decision Aid Intervention to Support Chinese American Dementia Caregivers in Feeding-Related Decisi · NA · not yet recruiting
NCT07441122 — Enhancing Attention in Elderly Using a Brain-Computer-Interface · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03696056 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Texas at Austin
Last refreshed: 9 November 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03696056.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing